Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF): SCENIC Trial
- Glaspole, Ian (Primary Chief Investigator (PCI))
- Symons, Karen M. (Project Manager)
Project: Research